Zonisamide and Oxybutynin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zonisamide (zonisamide) and Oxybutynin (oxybutynin). Common drug interactions include chronic kidney disease among females and abscess among males.

The phase IV clinical study analyzes what interactions people have when they take Zonisamide and Oxybutynin. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Zonisamide?

Zonisamide has active ingredients of zonisamide. It is often used in epilepsy. eHealthMe is studying from 11,445 Zonisamide users. Check the latest studies of Zonisamide.

What is Oxybutynin?

Oxybutynin has active ingredients of oxybutynin. It is often used in urge incontinence. eHealthMe is studying from 23,143 Oxybutynin users. Check the latest studies of Oxybutynin.



On Jul, 04, 2026

53 people who take Zonisamide and Oxybutynin together, and have interactions are studied.

Zonisamide and Oxybutynin drug interactions.

What are the common drug interactions of Zonisamide and Oxybutynin, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal injury (kidney injury)
  4. Fatigue (feeling of tiredness)
  5. Diarrhoea
  6. Fall
  7. Memory impairment
  8. Balance disorder
  9. Disturbance in attention
  10. Visual impairment

male:

  1. Abscess (pus)
  2. Anal fistula
  3. Gingivitis (inflammation of gums)
  4. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
  5. Nausea (feeling of having an urge to vomit)
  6. Pain
  7. Subcutaneous abscess
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Wound
  10. Infection

What are the common drug interactions of Zonisamide and Oxybutynin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Decreased appetite
  2. Fall
  3. Fatigue (feeling of tiredness)
  4. Memory impairment
  5. Personality change
  6. Visual impairment
  7. Wrist fracture
  8. Chronic kidney disease
  9. Constipation
  10. Diarrhoea

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal injury (kidney injury)
  4. Balance disorder
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Diarrhoea
  7. Disturbance in attention
  8. Fatigue (feeling of tiredness)
  9. Flushing (the warm, red condition of human skin)
  10. Memory impairment

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal injury (kidney injury)
  4. Balance disorder
  5. Dysstasia (difficulty in standing)
  6. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  7. Fall
  8. Gait disturbance
  9. Haematoma (collection of blood outside the blood vessels)
  10. Periorbital haematoma (collection of blood around the eyes)

60+:

  1. Chronic kidney disease
  2. Diarrhoea
  3. Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases)
  4. Burning sensation
  5. Cerebrospinal fluid leakage
  6. Decreased appetite
  7. Depressed mood
  8. Dermatitis allergic (inflammation of the skin due allergic reaction)
  9. Discomfort
  10. Drug hypersensitivity

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 16 people, 30.19%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 20.75%
  3. High Blood Cholesterol: 10 people, 18.87%
  4. Pain: 10 people, 18.87%
  5. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 10 people, 18.87%
  6. High Blood Pressure: 7 people, 13.21%
  7. Depression: 7 people, 13.21%
  8. Restless Leg Syndrome (a powerful urge to move your legs): 6 people, 11.32%
  9. Migraine (headache): 5 people, 9.43%
  10. Diabetes: 5 people, 9.43%

* Approximation only. Some reports may have incomplete information.

Do you take Zonisamide and Oxybutynin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zonisamide and Oxybutynin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zonisamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxybutynin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zonisamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxybutynin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on zonisamide and oxybutynin (the active ingredients of Zonisamide and Oxybutynin, respectively), and Zonisamide and Oxybutynin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: